220 related articles for article (PubMed ID: 27756605)
21. Hydroxytyrosol Attenuates LPS-Induced Acute Lung Injury in Mice by Regulating Autophagy and Sirtuin Expression.
Yang X; Jing T; Li Y; He Y; Zhang W; Wang B; Xiao Y; Wang W; Zhang J; Wei J; Lin R
Curr Mol Med; 2017; 17(2):149-159. PubMed ID: 28429673
[TBL] [Abstract][Full Text] [Related]
22. Anti-inflammatory effects of water extract of Taraxacum mongolicum hand.-Mazz on lipopolysaccharide-induced inflammation in acute lung injury by suppressing PI3K/Akt/mTOR signaling pathway.
Ma C; Zhu L; Wang J; He H; Chang X; Gao J; Shumin W; Yan T
J Ethnopharmacol; 2015 Jun; 168():349-55. PubMed ID: 25861954
[TBL] [Abstract][Full Text] [Related]
23. MiR-24 inhibits inflammatory responses in LPS-induced acute lung injury of neonatal rats through targeting NLRP3.
Lin Y; Yang Y
Pathol Res Pract; 2019 Apr; 215(4):683-688. PubMed ID: 30600184
[TBL] [Abstract][Full Text] [Related]
24. Therapeutic effect and mechanism study of L-cysteine derivative 5P39 on LPS-induced acute lung injury in mice.
He Y; Zhao Y; Feng Y; Ren A; Zhang Y; Wang Y; Li H
Eur J Pharmacol; 2020 Feb; 869():172893. PubMed ID: 31883915
[TBL] [Abstract][Full Text] [Related]
25. Preventive effects of valnemulin on lipopolysaccharide-induced acute lung injury in mice.
Chen Z; Zhang X; Chu X; Zhang X; Song K; Jiang Y; Yu L; Deng X
Inflammation; 2010 Oct; 33(5):306-14. PubMed ID: 20221680
[TBL] [Abstract][Full Text] [Related]
26. PKR suppress NLRP3-pyroptosis pathway in lipopolysaccharide-induced acute lung injury model of mice.
Zeng Y; Qin Q; Li K; Li H; Song C; Li Y; Dai M; Lin F; Mao Z; Li Q; Long Y; Fan Y; Pan P
Biochem Biophys Res Commun; 2019 Oct; 519(1):8-14. PubMed ID: 31474337
[TBL] [Abstract][Full Text] [Related]
27. Vasoactive intestinal peptide suppresses the NLRP3 inflammasome activation in lipopolysaccharide-induced acute lung injury mice and macrophages.
Zhou Y; Zhang CY; Duan JX; Li Q; Yang HH; Sun CC; Zhang J; Luo XQ; Liu SK
Biomed Pharmacother; 2020 Jan; 121():109596. PubMed ID: 31731193
[TBL] [Abstract][Full Text] [Related]
28. Andrographolide Derivative AL-1 Ameliorates LPS-induced Acute Lung Injury by Inhibiting NLRP3 Inflammasome and Lung Permeability.
Li T; Zhang C; Wei Y; Zhong H; Shan L; Yu P; Wang Y; Xu L
Curr Pharm Des; 2022; 28(30):2508-2517. PubMed ID: 35909279
[TBL] [Abstract][Full Text] [Related]
29. A COX-2/sEH dual inhibitor PTUPB alleviates lipopolysaccharide-induced acute lung injury in mice by inhibiting NLRP3 inflammasome activation.
Yang HH; Duan JX; Liu SK; Xiong JB; Guan XX; Zhong WJ; Sun CC; Zhang CY; Luo XQ; Zhang YF; Chen P; Hammock BD; Hwang SH; Jiang JX; Zhou Y; Guan CX
Theranostics; 2020; 10(11):4749-4761. PubMed ID: 32308747
[No Abstract] [Full Text] [Related]
30. Dihydromyricetin Alleviates Sepsis-Induced Acute Lung Injury through Inhibiting NLRP3 Inflammasome-Dependent Pyroptosis in Mice Model.
Wang YC; Liu QX; Zheng Q; Liu T; Xu XE; Liu XH; Gao W; Bai XJ; Li ZF
Inflammation; 2019 Aug; 42(4):1301-1310. PubMed ID: 30887396
[TBL] [Abstract][Full Text] [Related]
31. The effects of morin on lipopolysaccharide-induced acute lung injury by suppressing the lung NLRP3 inflammasome.
Tianzhu Z; Shihai Y; Juan D
Inflammation; 2014 Dec; 37(6):1976-83. PubMed ID: 24849134
[TBL] [Abstract][Full Text] [Related]
32. Crocin attenuates lipopolysacchride-induced acute lung injury in mice.
Wang J; Kuai J; Luo Z; Wang W; Wang L; Ke C; Li X; Ni Y
Int J Clin Exp Pathol; 2015; 8(5):4844-50. PubMed ID: 26191176
[TBL] [Abstract][Full Text] [Related]
33. Exogenous α-calcitonin gene-related peptide attenuates lipopolysaccharide-induced acute lung injury in rats.
Yang W; Xv M; Yang WC; Wang N; Zhang XZ; Li WZ
Mol Med Rep; 2015 Aug; 12(2):2181-8. PubMed ID: 25892548
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of glycolysis alleviates lipopolysaccharide-induced acute lung injury in a mouse model.
Zhong WJ; Yang HH; Guan XX; Xiong JB; Sun CC; Zhang CY; Luo XQ; Zhang YF; Zhang J; Duan JX; Zhou Y; Guan CX
J Cell Physiol; 2019 Apr; 234(4):4641-4654. PubMed ID: 30256406
[TBL] [Abstract][Full Text] [Related]
35. Protective effects of intratracheally administered quercetin on lipopolysaccharide-induced acute lung injury.
Takashima K; Matsushima M; Hashimoto K; Nose H; Sato M; Hashimoto N; Hasegawa Y; Kawabe T
Respir Res; 2014 Nov; 15(1):150. PubMed ID: 25413579
[TBL] [Abstract][Full Text] [Related]
36. Protective effect of cryptotanshinone on lipopolysaccharide-induced acute lung injury in mice.
Tang Y; Chen Y; Chu Z; Yan B; Xu L
Eur J Pharmacol; 2014 Jan; 723():494-500. PubMed ID: 24161915
[TBL] [Abstract][Full Text] [Related]
37. Rapamycin ameliorates lipopolysaccharide-induced acute lung injury by inhibiting IL-1β and IL-18 production.
Jia X; Cao B; An Y; Zhang X; Wang C
Int Immunopharmacol; 2019 Feb; 67():211-219. PubMed ID: 30557824
[TBL] [Abstract][Full Text] [Related]
38. Kegan Liyan oral liquid ameliorates lipopolysaccharide-induced acute lung injury through inhibition of TLR4-mediated NF-κB signaling pathway and MMP-9 expression.
Zhang X; Sun CY; Zhang YB; Guo HZ; Feng XX; Peng SZ; Yuan J; Zheng RB; Chen WP; Su ZR; Huang XD
J Ethnopharmacol; 2016 Jun; 186():91-102. PubMed ID: 27036629
[TBL] [Abstract][Full Text] [Related]
39. Eriodictyol ameliorates lipopolysaccharide-induced acute lung injury by suppressing the inflammatory COX-2/NLRP3/NF-κB pathway in mice.
Wang X; Deng R; Dong J; Huang L; Li J; Zhang B
J Biochem Mol Toxicol; 2020 Mar; 34(3):e22434. PubMed ID: 31860763
[TBL] [Abstract][Full Text] [Related]
40. Protective effect of veratric acid on lipopolysaccharide-induced acute lung injury in mice.
Ran X; Chao S; Jun-Gang Z; Yun H; Kuan-Bing C; Wen-Jun S
Eur J Pharmacol; 2014 Oct; 740():227-32. PubMed ID: 25034806
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
